Roots-Analysis-Logo.png
The TCR-based therapies market is projected to be worth around USD 4.4 billion, by 2030, claims Roots Analysis
July 15, 2021 08:45 ET | Roots Analysis
London, July 15, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “TCR-based Therapies Market, 2021-2030” report to its list of offerings. Modified TCR-based adoptive T-cell...
Roots-Analysis-Logo.png
The cell line development and characterization services markets are projected to be worth over USD 12 billion by 2030, claims Roots Analysis
July 14, 2021 08:45 ET | Roots Analysis
London, July 14, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of Cell Line Development and Characterization Services Market, 2020- 2030 report to its list of offerings. The...
Roots-Analysis-Logo.png
The cell and gene therapy contract research services market is anticipated to grow at annualized rate of CAGR 28.9% till 2030, claims Roots Analysis
July 13, 2021 09:00 ET | Roots Analysis
London, July 13, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Cell and Gene Therapy CROs Market (2nd Edition), 2021-2030” report to its list of offerings. Despite the...
Roots-Analysis-Logo.png
The antibody purification services market is projected to be worth USD 2.02 billion by 2030, growing at an annualized rate of ~10%, claims Roots Analysis
July 08, 2021 09:00 ET | Roots Analysis
London, July 08, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Global Antibody Purification Services Market, 2021-2030 report to its list of offerings. Isolation and...
Roots-Analysis-Logo.png
The vascular disrupting agents market is projected to be worth USD 2 billion by 2030, growing at an annualized rate of over 60%, claims Roots Analysis
July 07, 2021 08:45 ET | Roots Analysis
London, July 07, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Vascular Disrupting Agents Market, 2021-2030” report to its list of offerings. Despite multiple cancer...
Roots-Analysis-Logo.png
The biopharmaceutical CROs market is projected to be worth USD 67 billion by 2030, claims Roots Analysis
July 06, 2021 08:30 ET | Roots Analysis
London, July 06, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Biopharmaceutical CROs Market, 2021-2030,” report to its list of offerings. Given their numerous advantages,...
Roots-Analysis-Logo.png
The cell therapy manufacturing market is projected to reach USD 14.5 billion by 2030, growing at an annualized rate of 18%, claims Roots Analysis
July 01, 2021 08:00 ET | Roots Analysis
London, July 01, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (4th Edition), 2021-2030” report to its list of offerings. Owing to the...
Roots-Analysis-Logo.png
The immunocytokines market is estimated to be worth around USD 5.4 billion by 2030, claims Roots Analysis
June 30, 2021 10:55 ET | Roots Analysis
London, June 30, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of the “Immunocytokines Market, 2021-2030” report to its list of offerings. These engineered...
Roots-Analysis-Logo.png
The modular facility manufacturers market is projected to be worth over USD 6.4 billion by 2030, growing at a CAGR of 8.8%, claims Roots Analysis
June 10, 2021 09:00 ET | Roots Analysis
London, June 10, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Modular Facilities in Pharmaceutical and Biotechnology Market (2nd Edition) by Type of Modular Construct, Type...
Roots-Analysis-Logo.png
The cloud-based solutions for drug discovery, development and manufacturing market is projected to grow at a CAGR of 15.4%, claims Roots Analysis
June 09, 2021 09:00 ET | Roots Analysis
London, June 09, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market by Type of Cloud (Private,...